Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what discussions they have had on access to Pre-Exposure Prophylaxis (PrEP), and the Department of Health’s role in ensuring that NHS England provides continuity of access to PrEP to those currently using the drug.

The PROUD trial participants continue to receive pre-exposure prophylaxis (PrEP) at the current time. We are working with Public Health England to ensure that the on-going needs of these individuals are taken into account in planning for the PrEP trial sites in which NHS England has agreed to invest up to £2 million.